RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.43
−8.59%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.29
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.19
- EPS estimate
- -$0.39
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -78.3%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.39 | -$0.19 | Beat 50.65% | — |
| May 14, 2026 | -$0.35 | -$0.46 | Miss -29.58% | — |
| Mar 30, 2026 | -$1.09 | -$5.21 | Miss -379.87% | — |
| Nov 13, 2025 | -$0.11 | -$0.06 | Beat 45.45% | — |
| Aug 14, 2025 | -$0.15 | -$0.12 | Beat 20.00% | — |
| May 15, 2025 | -$0.21 | -$0.13 | Beat 38.10% | — |
| Mar 31, 2025 | -$0.22 | -$0.15 | Beat 31.82% | — |
| Nov 14, 2024 | -$0.23 | -$0.25 | Miss -8.70% | — |
| Aug 14, 2024 | -$0.28 | -$0.26 | Beat 7.14% | — |
| Apr 15, 2024 | -$0.35 | -$0.35 | In line | — |
| Nov 14, 2023 | -$0.35 | -$0.44 | Miss -25.71% | — |
| Aug 14, 2023 | -$0.29 | -$0.55 | Miss -89.66% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026